Innospec Inc. (IOSP) stock
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3026% below fair value
$80.39+1.28 (+1.62%)
Close on Nov 13, 2026Market cap $1.98BP/E –Yield 2.13%
Innospec ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Innospec's ebitda for the twelve months ending Sep 30, 2026 was $203.60M, up 20.5% year over year. For fiscal 2025 it was $173.10M, down 21.8% from the year before. Over ten years it grew -1.0% a year on average. The highest annual figure on record is $227.40M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $173.10M | -21.8% |
| FY2024 | Dec 31, 2024 | $221.40M | +10.2% |
| FY2023 | Dec 31, 2023 | $200.90M | -11.7% |
| FY2022 | Dec 31, 2022 | $227.40M | +30.1% |
| FY2021 | Dec 31, 2021 | $174.80M | +119.3% |
| FY2020 | Dec 31, 2020 | $79.70M | -59.6% |
| FY2019 | Dec 31, 2019 | $197.50M | +7.9% |
| FY2018 | Dec 31, 2018 | $183.10M | +4.4% |
| FY2017 | Dec 31, 2017 | $175.40M | +28.7% |
| FY2016 | Dec 31, 2016 | $136.30M | -28.8% |
| FY2015 | Dec 31, 2015 | $191.50M | +35.2% |
| FY2014 | Dec 31, 2014 | $141.60M | +27.6% |
| FY2013 | Dec 31, 2013 | $111.00M | +2.8% |
| FY2012 | Dec 31, 2012 | $108.00M | +75.3% |
| FY2011 | Dec 31, 2011 | $61.60M | -29.7% |
| FY2010 | Dec 31, 2010 | $87.60M | +124.0% |
| FY2009 | Dec 31, 2009 | $39.10M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $51.30M | +183.4% |
| Q2 FY2026 | Jun 30, 2026 | $49.70M | +9.5% |
| Q1 FY2026 | Mar 31, 2026 | $46.40M | -13.1% |
| Q4 FY2025 | Dec 31, 2025 | $56.20M | +8.1% |
| Q3 FY2025 | Sep 30, 2025 | $18.10M | -68.1% |
| Q2 FY2025 | Jun 30, 2025 | $45.40M | -12.4% |
| Q1 FY2025 | Mar 31, 2025 | $53.40M | -12.3% |
| Q4 FY2024 | Dec 31, 2024 | $52.00M | -4.9% |
| Q3 FY2024 | Sep 30, 2024 | $56.70M | +9.5% |
| Q2 FY2024 | Jun 30, 2024 | $51.80M | +17.5% |
| Q1 FY2024 | Mar 31, 2024 | $60.90M | +21.1% |
| Q4 FY2023 | Dec 31, 2023 | $54.70M | -2.0% |
| Q3 FY2023 | Sep 30, 2023 | $51.80M | -14.0% |
| Q2 FY2023 | Jun 30, 2023 | $44.10M | -22.1% |
| Q1 FY2023 | Mar 31, 2023 | $50.30M | -8.2% |
| Q4 FY2022 | Dec 31, 2022 | $55.80M | +18.0% |
| Q3 FY2022 | Sep 30, 2022 | $60.20M | +44.4% |
| Q2 FY2022 | Jun 30, 2022 | $56.60M | +19.7% |
| Q1 FY2022 | Mar 31, 2022 | $54.80M | +42.3% |
| Q4 FY2021 | Dec 31, 2021 | $47.30M | +18.0% |
| Q3 FY2021 | Sep 30, 2021 | $41.70M | +49.5% |
| Q2 FY2021 | Jun 30, 2021 | $47.30M | – |
| Q1 FY2021 | Mar 31, 2021 | $38.50M | -27.2% |
| Q4 FY2020 | Dec 31, 2020 | $40.10M | -27.2% |
| Q3 FY2020 | Sep 30, 2020 | $27.90M | -45.0% |
| Q2 FY2020 | Jun 30, 2020 | -$41.20M | -193.8% |
| Q1 FY2020 | Mar 31, 2020 | $52.90M | +10.7% |
| Q4 FY2019 | Dec 31, 2019 | $55.10M | +0.9% |
| Q3 FY2019 | Sep 30, 2019 | $50.70M | +10.2% |
| Q2 FY2019 | Jun 30, 2019 | $43.90M | +7.1% |
| Q1 FY2019 | Mar 31, 2019 | $47.80M | +15.2% |
| Q4 FY2018 | Dec 31, 2018 | $54.60M | +8.3% |
| Q3 FY2018 | Sep 30, 2018 | $46.00M | +10.3% |
| Q2 FY2018 | Jun 30, 2018 | $41.00M | -10.3% |
| Q1 FY2018 | Mar 31, 2018 | $41.50M | +10.4% |
| Q4 FY2017 | Dec 31, 2017 | $50.40M | +45.2% |
| Q3 FY2017 | Sep 30, 2017 | $41.70M | – |
| Q2 FY2017 | Jun 30, 2017 | $45.70M | – |
| Q1 FY2017 | Mar 31, 2017 | $37.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $34.70M | – |
See a number that looks wrong?